Dataset Information


Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases

ABSTRACT: The functional status of the tumor repressor protein (TP53 or TRP53) is a defining feature of ovarian cancer. Mutant or null alleles of TP53 are expressed in greater than 90% of all high-grade serous adenocarcinomas. Wild type TP53 is elevated in low-grade serous adenocarcinomas in women and in our Pten/Kras/Amhr2-Cre mutant mouse model. Disruption of the Trp53 gene in this mouse model did not lead to high-grade ovarian cancer but did increase expression of estrogen receptor alpha (ERalpha; ESR1) and markedly enhanced the responsiveness of these cells to estrogen. Specifically, when Trp53 positive and Trp53 null mutant mice were treated with estradiol or vehicle, only the Trp53 null and Esr1 positive tumors respond vigorously to estradiol in vivo and exhibit features characteristic of high-grade type ovarian cancer: invasive growth into the ovarian stroma, rampant metastases to the peritoneal cavity and signs of genomic instability. Estrogen promoted and progesterone suppressed the growth of Trp53 null ovarian tumors and tumor cells injected intraperitoneally (IP), subcutaneously (SC) or when grown in matrigel. Exposure of the Trp53 depleted cells to estrogen also has a profound impact on the tumor microenvironment and immune-related events. These results led to the new paradigm that TRP53 status is related to the susceptibility of transformed ovarian surface epithelial (OSE) cells to estradiol-induced metastases and genomic instability. This novel finding is relevant not only for women during their reproductive years but also for women on hormone (estradiol) replacement therapies. A direct comparison of ovarian surface epithelia cells from two different genotype mice

ORGANISM(S): Mus musculus

PROVIDER: E-GEOD-51095 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2014-03-21 | E-GEOD-51095 | ArrayExpress
| S-EPMC4873372 | BioStudies
| S-EPMC3320246 | BioStudies
| E-GEOD-34882 | BioStudies
2012-06-20 | E-GEOD-34882 | ArrayExpress
| S-EPMC3139785 | BioStudies
| S-EPMC6212416 | BioStudies
| S-EPMC3163504 | BioStudies
2013-01-01 | S-EPMC3620412 | BioStudies
| S-EPMC4059202 | BioStudies